<DOC>
	<DOCNO>NCT02839434</DOCNO>
	<brief_summary>Oral anticoagulant increasingly prescribe discontinue invasive cardiac procedure . Additional parenteral anticoagulation necessary procedure ( FA ablation invasive coronary exploration ) . The unfractionated heparin dos adapt monitor test heparin , activate clotting time ( ACT ) aim obtain maintain ACT &gt; 300-400 sec . This goal whether patient oral anticoagulant treatment , regardless initial level anticoagulation . The effect oral anticoagulant routine coagulation test ( PT , APTT , TT ) well document , data publish effect heparin monitoring test , particularly ACT . The aim stuy redefine target value ACT unfractionated heparin dos administer optimize efficacy / safety invasive procedure cardiology .</brief_summary>
	<brief_title>Evaluation Interference Antithrombotic Agents With Laboratory Monitoring Heparin Therapy</brief_title>
	<detailed_description />
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>patient treat oral anticoagulant curative dose require require venous blood sample management opposition patient participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>